EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterization of dosimetric predictors for pulmonary perfusion changes before and after hypofractionated whole‐breast radiotherapy in node‐negative breast cancer patients: A prospective study

Farzaneh Allaveisi, Nima Esmaeilzadeh, Siamak Derakhshan, Smaneh Jamshidi Dizaji, Aian Azadnia

Journal of Applied Clinical Medical Physics · 2026

DOI: 10.1002/acm2.70641 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Clinical Medical Physics, 2026. Verfasst von Farzaneh Allaveisi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Physics, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran. Hauptthemen laut MEDLINE: Breast Neoplasms, Radiotherapy Planning, Computer-Assisted, Radiation Pneumonitis, Radiation Dose Hypofractionation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer is the most common malignancy in women, and adjuvant radiotherapy is an essential component of curative treatment. Despite advances in hypofractionated whole‐breast irradiation (HF‐WBI), incidental lung exposure remains unavoidable and predisposes to radiation‐induced pulmonary injury, including radiation pneumonitis (RP). Traditional predictors such as mean lung dose (MLD) may inadequately capture the heterogeneous intrapulmonary dose distribution typical of breast radiotherapy.

Purpose

The purpose of this study was to evaluate whether heterogeneity‐sensitive dosimetric metrics and functional lung imaging better predict radiation‐induced perfusion changes and RP in patients undergoing HF‐WBI.

Methods

In this prospective study, 48 node‐negative breast cancer patients treated with conformal HF‐WBI were evaluated. Pulmonary perfusion scans (PPS) were acquired pre‐RT and 6–9 months post‐RT. Dose–volume histogram (DVH) parameters, including MLD, uniform effective dose (D eff ), and V 5 –V 40 , were extracted from three‐dimensional conformal radiotherapy (3DCRT) or forward‐planned intensity‐modulated RT (FIMRT) plans. D eff was calculated using the Lyman–Kutcher–Burman (LKB) model to integrate dose heterogeneity. Associations between dosimetric metrics, perfusion changes, and RP were analyzed using correlation and ROC analysis.

Results

PPS revealed modest but detectable post‐RT perfusion declines, most pronounced in lung regions receiving higher doses. Three patients (6.3%) developed Grade 2 RP. D eff and high‐dose lung volumes (V 35 –V 40 ) demonstrated the strongest correlations with perfusion loss and RP (AUC 0.81–0.85, p < 0.01), whereas MLD showed weaker predictive value. ROC analysis identified clinically relevant thresholds: D eff ≤ 13.6 Gy, V 35 ≤ 37.5%, V 40 ≤ 32%, and a ≥4% decline in total perfusion, below which minimal functional impairment and RP were observed.

Conclusions

D eff and high‐dose volumetric constraints outperform MLD in predicting decrease in lung perfusion in HF‐WBI. Quantitative PPS provides complementary functional validation, and integration of dosimetric and functional parameters may refine lung‐sparing strategies in breast radiotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsRadiotherapy Planning, Computer-AssistedRadiation PneumonitisRadiation Dose HypofractionationOrgans at RiskLungHumansFemaleProspective StudiesRadiotherapy DosageRadiotherapy, Intensity-ModulatedRadiotherapy, ConformalMiddle AgedAgedPrognosisAdultRadiometry

Stichwörter der Autor:innen

SPECT imagingbreast cancerdosimetric parametershypofractionated radiotherapypulmonary function testspulmonary perfusion scan

Autor:innen und Institutionen

  • Department of Medical Physics, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran.
  • Department of Student Research, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran.
  • Department of Radiotherapy, Faculty of Paramedicine, Kurdistan University of Medical Sciences, Sanandaj, Iran.
  • Liver and Digestive Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran.

Zitieren

APA

Allaveisi, F., Esmaeilzadeh, N., Derakhshan, S., Jamshidi Dizaji, S., & Azadnia, A. (2026). Characterization of dosimetric predictors for pulmonary perfusion changes before and after hypofractionated whole‐breast radiotherapy in node‐negative breast cancer patients: A prospective study. Journal of Applied Clinical Medical Physics. https://doi.org/10.1002/acm2.70641

Vancouver

Allaveisi F, Esmaeilzadeh N, Derakhshan S, Jamshidi Dizaji S, Azadnia A. Characterization of dosimetric predictors for pulmonary perfusion changes before and after hypofractionated whole‐breast radiotherapy in node‐negative breast cancer patients: A prospective study. Journal of Applied Clinical Medical Physics. 2026. doi:10.1002/acm2.70641

BibTeX
@article{Allaveisi2026,
  author = {Allaveisi, Farzaneh and Esmaeilzadeh, Nima and Derakhshan, Siamak and Jamshidi Dizaji, Smaneh and Azadnia, Aian},
  title = {Characterization of dosimetric predictors for pulmonary perfusion changes before and after hypofractionated whole‐breast radiotherapy in node‐negative breast cancer patients: A prospective study},
  journal = {Journal of Applied Clinical Medical Physics},
  year = {2026},
  doi = {10.1002/acm2.70641}
}
Kostenlos starten →